Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement
Files
Publication date
2025-09-21
Authors
Mathijssen, Harold
Bawaskar, Parag H
Rochlani, Yogita
Georgy, Issac
Athwal, Pal Satyajit Singh
Guo, Yugene
Pollmann, Daniel
Markowitz, Jeremy
Von Wald, Lisa
Roukoz, Henri
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
BACKGROUND AND AIMS: Implementing societal recommendations for primary prevention implantable cardioverter-defibrillators (ICDs) in cardiac sarcoidosis requires an accurate diagnosis. However, cardiac sarcoidosis diagnostic schemes are inconsistent and often produce conflicting results. This study aimed to compare the discriminative accuracy of cardiovascular magnetic resonance imaging (CMR) phenotyping with the societal recommendations for predicting long-term ventricular arrhythmic outcomes in patients with suspected cardiac sarcoidosis, regardless of their diagnostic status. METHODS: This multicentre study included patients with histology-supported sarcoidosis who underwent CMR for suspected cardiac involvement and were ineligible for secondary prevention ICDs. The study outcome was a composite of fatal or life-threatening ventricular arrhythmias. Outcomes were compared based on eligibility for ICDs by societal recommendations and CMR phenotyping. RESULTS: Among 1514 patients, 84 experienced the study outcome during a median follow-up of 4.5 years and a maximum follow-up of 10 years. The high-risk CMR phenotype was associated with higher 5- and 10-year incidences of the outcome (24.0% and 35.0%, respectively) compared with those who met societal recommendations. Patients with low-risk phenotypes had lower incidences (0.7% and 2.6%). Cardiovascular magnetic resonance imaging phenotyping outperformed societal recommendations in discriminative accuracy, with areas under the curve of 0.861 and 0.776 for 5- and 10-year outcomes, respectively. Additionally, CMR phenotyping had the highest adjusted subdistribution hazard ratio (19.8) for the study outcome. CONCLUSIONS: In patients with suspected cardiac sarcoidosis, CMR phenotyping showed greater discriminative accuracy than societal recommendations for predicting fatal or life-threatening ventricular arrhythmias, suggesting that it may be more effective at identifying candidates for primary prevention ICDs.
Keywords
Cardiac sarcoidosis, Cardiovascular magnetic resonance imaging, ICD decision-making, Primary prevention, Risk stratification, Taverne, Journal Article
Citation
Mathijssen, H, Bawaskar, P H, Rochlani, Y, Georgy, I, Athwal, P S S, Guo, Y, Pollmann, D, Markowitz, J, Von Wald, L, Roukoz, H, Perlman, D, Bhargava, M, Slipczuk, L, Filtz, A, Ramos, J A O, Samant, S, Chhikara, S, Castagna, F, Veltkamp, M, Akdim, F, Bakker, A L M, Post, M C & Shenoy, C 2025, 'Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis : a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement', European heart journal, vol. 46, no. 36, pp. 3583–3596. https://doi.org/10.1093/eurheartj/ehaf338